Last update 01 Nov 2024

H1N1 influenza A vaccine (split virion, inactivated), Hualan Biological Engineering(Hualan Biological Bacterin Co., Ltd.)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms-
Target-
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Influenza, Human
Inactive Indication-
Originator Organization
Hualan Biological Vaccine, Inc.Hualan Biological Vaccine, Inc.
Active Organization
Hualan Biological Vaccine, Inc.Hualan Biological Vaccine, Inc.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (04 Sep 2009),
Influenza, Human
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with H1N1 influenza A vaccine (split virion, inactivated), Hualan Biological Engineering(Hualan Biological Bacterin Co., Ltd.)
JPRN-UMIN000028530 / CompletedPhase 1IIT
A phase1 study of Hydroxypropyl-beta-cyclodextrin(HP-beta-CyD)-adjuvanted influenza split vaccine - A phase1 study of Hydroxypropyl-beta-cyclodextrin(HP-beta-CyD)-adjuvanted influenza split vaccine
NCT01554826 / CompletedPhase 3
A Double - Blind, Randomized, - Controlled Clinical Trial With Inactivated Influenza Vaccine (Split Virion)(0.25ml Formulation for Pediatric Use)
100 Clinical Results associated with H1N1 influenza A vaccine (split virion, inactivated), Hualan Biological Engineering(Hualan Biological Bacterin Co., Ltd.)
Login to view more data
100 Translational Medicine associated with H1N1 influenza A vaccine (split virion, inactivated), Hualan Biological Engineering(Hualan Biological Bacterin Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with H1N1 influenza A vaccine (split virion, inactivated), Hualan Biological Engineering(Hualan Biological Bacterin Co., Ltd.)
Login to view more data
100 Deals associated with H1N1 influenza A vaccine (split virion, inactivated), Hualan Biological Engineering(Hualan Biological Bacterin Co., Ltd.)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
J07BB02
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza, Human
CN
Hualan Biological Vaccine, Inc.Hualan Biological Vaccine, Inc.
04 Sep 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free